LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 238

Search options

  1. Article ; Online: Pathogenesis of refractory ITP: Overview.

    Cines, Douglas B

    British journal of haematology

    2023  Volume 203, Issue 1, Page(s) 10–16

    Abstract: A subset of individuals with 'primary' or 'idiopathic' immune thrombocytopenia (ITP) who fail to respond to conventional first- and second-line agents or who lose responsiveness are considered to have 'refractory' disease (rITP), placing them at ... ...

    Abstract A subset of individuals with 'primary' or 'idiopathic' immune thrombocytopenia (ITP) who fail to respond to conventional first- and second-line agents or who lose responsiveness are considered to have 'refractory' disease (rITP), placing them at increased risk of bleeding and complications of intensive treatment. However, the criteria used to define the refractory state vary among studies, which complicates research and clinical investigation. Moreover, it is unclear whether rITP is simply 'more severe' ITP, or if there are specific pathogenic pathways that are more likely to result in refractory disease, and whether the presence or development of rITP can be established or anticipated based on these differences. This paper reviews potential biological features that may be associated with rITP, including genetic and epigenetic risk factors, dysregulation of T cells and cytokine networks, antibody affinity and specificity, activation of complement, impaired platelet production and alterations in platelet viability and clearance. These findings indicate the need for longitudinal studies using novel clinically available methodologies to identify and monitor pathogenic T cells, platelet antibodies and other clues to the development of refractory disease.
    MeSH term(s) Humans ; Purpura, Thrombocytopenic, Idiopathic/etiology ; Purpura, Thrombocytopenic, Idiopathic/therapy ; Antibodies ; Antibody Affinity ; Blood Platelets ; Cytokines ; Thrombocytopenia
    Chemical Substances Antibodies ; Cytokines
    Language English
    Publishing date 2023-09-21
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.19083
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vaccine-induced immune thrombotic thrombocytopenia.

    Cines, Douglas B / Greinacher, Andreas

    Blood

    2023  Volume 141, Issue 14, Page(s) 1659–1665

    Abstract: Within the first months of the COVID-19 vaccination campaign, previously healthy recipients who developed severe thrombosis (often cerebral and/or splanchnic vasculature) and thrombocytopenia typically after adenoviral vector-based vaccination were ... ...

    Abstract Within the first months of the COVID-19 vaccination campaign, previously healthy recipients who developed severe thrombosis (often cerebral and/or splanchnic vasculature) and thrombocytopenia typically after adenoviral vector-based vaccination were identified. Similarities between this syndrome, vaccine-induced immune thrombotic thrombocytopenia (VITT), and heparin-induced thrombocytopenia prompted recognition of the role of antiplatelet factor 4 (PF4) antibodies and management strategies based on IV immunoglobulin and nonheparin anticoagulants, which improved outcome. We update current understanding of VITT and potential involvement of anti-PF4 antibodies in thrombotic disorders.
    MeSH term(s) Humans ; COVID-19 Vaccines/adverse effects ; COVID-19 ; Purpura, Thrombocytopenic, Idiopathic/chemically induced ; Purpura, Thrombocytopenic, Idiopathic/therapy ; Thrombocytopenia/chemically induced ; Thrombosis/etiology ; Vaccines ; Platelet Factor 4
    Chemical Substances COVID-19 Vaccines ; Vaccines ; Platelet Factor 4 (37270-94-3)
    Language English
    Publishing date 2023-01-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2022017696
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Primary Immune Thrombocytopenia in Pregnancy. Reply.

    Bussel, James B / Hou, Ming / Cines, Douglas B

    The New England journal of medicine

    2023  Volume 389, Issue 18, Page(s) 1728

    MeSH term(s) Pregnancy ; Female ; Humans ; Purpura, Thrombocytopenic, Idiopathic/complications ; Purpura, Thrombocytopenic, Idiopathic/diagnosis ; Thrombocytopenia/immunology ; Platelet Count
    Language English
    Publishing date 2023-11-01
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2310642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Management of Primary Immune Thrombocytopenia in Pregnancy.

    Bussel, James B / Hou, Ming / Cines, Douglas B

    The New England journal of medicine

    2023  Volume 389, Issue 6, Page(s) 540–548

    MeSH term(s) Female ; Humans ; Pregnancy ; Purpura, Thrombocytopenic, Idiopathic/complications ; Purpura, Thrombocytopenic, Idiopathic/therapy ; Pregnancy Complications, Hematologic/therapy
    Language English
    Publishing date 2023-08-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMra2214617
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Platelets get particular.

    Rauova, Lubica / Cines, Douglas B

    Blood

    2021  Volume 140, Issue 5, Page(s) 413–414

    MeSH term(s) Blood Platelets/physiology ; ChAdOx1 nCoV-19 ; Humans ; Immunity ; Leukopenia ; Thrombocytopenia
    Chemical Substances ChAdOx1 nCoV-19 (B5S3K2V0G8)
    Language English
    Publishing date 2021-11-03
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2022016773
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

    Cines, Douglas B / Bussel, James B

    The New England journal of medicine

    2021  Volume 384, Issue 23, Page(s) 2254–2256

    MeSH term(s) COVID-19 ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; Humans ; SARS-CoV-2 ; Thrombocytopenia/chemically induced ; Vaccination
    Chemical Substances COVID-19 Vaccines ; ChAdOx1 nCoV-19 (B5S3K2V0G8)
    Language English
    Publishing date 2021-04-16
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMe2106315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Diagnosing HIT: the need for speed.

    Cuker, Adam / Cines, Douglas B

    Blood

    2020  Volume 135, Issue 14, Page(s) 1082–1083

    MeSH term(s) Bayes Theorem ; Humans ; Thrombocytopenia
    Language English
    Publishing date 2020-04-03
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2019004676
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Pathogenesis of heparin-induced thrombocytopenia.

    Arepally, Gowthami M / Cines, Douglas B

    Translational research : the journal of laboratory and clinical medicine

    2020  Volume 225, Page(s) 131–140

    Abstract: There are currently no effective substitutes for high intensity therapy with unfractionated heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of monitoring and reversibility. The continued use of UFH in these and other ... ...

    Abstract There are currently no effective substitutes for high intensity therapy with unfractionated heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of monitoring and reversibility. The continued use of UFH in these and other settings requires vigilance for its most serious nonhemorrhagic complication, heparin induced thrombocytopenia (HIT). HIT is an immune prothrombotic disorder caused by antibodies that recognize complexes between platelet factor 4 (PF4) and polyanions such as heparin (H).The pathogenicity of anti-PF4/H antibodies is likely due to the formation of immune complexes that initiate intense procoagulant responses by vascular and hematopoietic cells that lead to the generation of platelet microparticles, monocyte and endothelial cell procoagulant activity, and neutrophil extracellular traps, among other outcomes. The development of anti-PF4/H antibodies after exposure to UFH greatly exceeds the incidence of clinical disease, but the biochemical features that distinguish pathogenic from nonpathogenic antibodies have not been identified. Diagnosis relies on pretest clinical probability, screening for anti-PF4/H antibodies and documentation of their platelet activating capacity. However, both clinical algorithms and test modalities have limited predictive values making diagnosis and management challenging. Given the unacceptable rates of recurrent thromboembolism and bleeding associated with current therapies, there is an unmet need for novel rational nonanticoagulant therapeutics based on the pathogenesis of HIT. We will review recent developments in our understanding of the pathogenesis of HIT and its implications for future approaches to diagnosis and management.
    MeSH term(s) Anticoagulants/therapeutic use ; Heparin/adverse effects ; Humans ; Thrombocytopenia/chemically induced ; Thrombocytopenia/drug therapy ; Thrombocytopenia/physiopathology
    Chemical Substances Anticoagulants ; Heparin (9005-49-6)
    Language English
    Publishing date 2020-05-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2246684-8
    ISSN 1878-1810 ; 1532-6543 ; 1931-5244
    ISSN (online) 1878-1810 ; 1532-6543
    ISSN 1931-5244
    DOI 10.1016/j.trsl.2020.04.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: COVID-19 vaccination and immune thrombocytopenia.

    Pishko, Allyson M / Bussel, James B / Cines, Douglas B

    Nature medicine

    2021  Volume 27, Issue 7, Page(s) 1145–1146

    MeSH term(s) COVID-19 ; COVID-19 Vaccines ; Humans ; Purpura, Thrombocytopenic, Idiopathic ; SARS-CoV-2 ; Vaccination
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-06-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1220066-9
    ISSN 1546-170X ; 1078-8956
    ISSN (online) 1546-170X
    ISSN 1078-8956
    DOI 10.1038/s41591-021-01419-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The child with immune thrombocytopenia: to treat or not to treat, is that still the question?

    Cooper, Nichola / Cines, Douglas B

    Haematologica

    2019  Volume 104, Issue 11, Page(s) 2132–2134

    MeSH term(s) Child ; Humans ; Purpura, Thrombocytopenic, Idiopathic ; Receptors, Fc ; Recombinant Fusion Proteins ; Thrombocytopenia ; Thrombopoietin
    Chemical Substances Receptors, Fc ; Recombinant Fusion Proteins ; Thrombopoietin (9014-42-0) ; romiplostim (GN5XU2DXKV)
    Language English
    Publishing date 2019-10-30
    Publishing country Italy
    Document type Editorial ; Comment
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2019.229179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top